17-8173460-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_183065.4(TMEM107):c.*743G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.671 in 762,934 control chromosomes in the GnomAD database, including 173,740 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.66 ( 33780 hom., cov: 33)
Exomes 𝑓: 0.67 ( 139960 hom. )
Consequence
TMEM107
NM_183065.4 3_prime_UTR
NM_183065.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.55
Genes affected
TMEM107 (HGNC:28128): (transmembrane protein 107) This gene encodes a transmembrane protein and component of the primary cilia transition zone. The encoded protein regulates ciliogenesis and ciliary protein composition. Human fibroblasts expressing a mutant allele of this gene exhibit reduced numbers of cilia, altered cilia length, and impaired sonic hedgehog signaling. In human patients, different mutations in this gene cause different ciliopathies, including Meckel-Gruber syndrome and orofaciodigital syndrome. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 17-8173460-C-T is Benign according to our data. Variant chr17-8173460-C-T is described in ClinVar as [Benign]. Clinvar id is 1168310.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.707 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM107 | NM_183065.4 | c.*743G>A | 3_prime_UTR_variant | 5/5 | ENST00000437139.7 | NP_898888.1 | ||
SNORD118 | NR_033294.2 | n.129G>A | non_coding_transcript_exon_variant | 1/1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM107 | ENST00000437139.7 | c.*743G>A | 3_prime_UTR_variant | 5/5 | 1 | NM_183065.4 | ENSP00000402732 | P1 | ||
TMEM107 | ENST00000449985.6 | c.*792G>A | 3_prime_UTR_variant | 2/2 | 1 | ENSP00000404753 | ||||
SNORD118 | ENST00000363593.1 | n.128G>A | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.665 AC: 100869AN: 151714Hom.: 33756 Cov.: 33
GnomAD3 genomes
AF:
AC:
100869
AN:
151714
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.668 AC: 154482AN: 231344Hom.: 52314 AF XY: 0.668 AC XY: 85277AN XY: 127702
GnomAD3 exomes
AF:
AC:
154482
AN:
231344
Hom.:
AF XY:
AC XY:
85277
AN XY:
127702
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.673 AC: 411154AN: 611100Hom.: 139960 Cov.: 0 AF XY: 0.674 AC XY: 225037AN XY: 334022
GnomAD4 exome
AF:
AC:
411154
AN:
611100
Hom.:
Cov.:
0
AF XY:
AC XY:
225037
AN XY:
334022
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.665 AC: 100940AN: 151834Hom.: 33780 Cov.: 33 AF XY: 0.670 AC XY: 49722AN XY: 74190
GnomAD4 genome
AF:
AC:
100940
AN:
151834
Hom.:
Cov.:
33
AF XY:
AC XY:
49722
AN XY:
74190
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 19, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
TMEM107-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 22, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at